SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-09-001458
Filing Date
2009-03-02
Accepted
2009-03-02 16:34:43
Documents
14
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 ALNYLAM PHARMACEUTICALS, INC. b73445ape10vk.htm 10-K 1462607
2 EX-10.23 RESEARCH COLLABORATION AND LICENSE AGREEMENT b73445apexv10w23.txt EX-10.23 273140
3 EX-10.26 LICENSE AND COLLABORATION AGREEMENT b73445apexv10w26.htm EX-10.26 529379
4 EX-21.1 SUBSIDIARIES OF THE REGISTRANT b73445apexv21w1.htm EX-21.1 2277
5 EX-23.1 CONSENT OF PRICEWATERHOUSECOOPERS LLP b73445apexv23w1.htm EX-23.1 1279
6 EX-23.2 CONSENT OF ERNST & YOUNG LLP b73445apexv23w2.htm EX-23.2 1909
7 EX-31.1 SECTION 302 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER b73445apexv31w1.htm EX-31.1 8325
8 EX-31.2 SECTION 302 CERTIFICATION OF THE VICE PRESIDENT OF FINANCE AND TREASURER b73445apexv31w2.htm EX-31.2 8603
9 EX-32.1 SECTION 906 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER b73445apexv32w1.htm EX-32.1 3376
10 EX-32.2 SECTION 906 CERTIFICATION OF THE VICE PRESIDENT OF FINANCE AND TREASURER b73445apexv32w2.htm EX-32.2 3446
11 EX-99.1 REGULUS THERAPEUTICS LLC FINANCIAL STATEMENTS b73445apexv99w1.htm EX-99.1 104928
12 GRAPHIC b73445apb7344501.gif GRAPHIC 11734
13 GRAPHIC b73445apb7344502.gif GRAPHIC 9344
14 GRAPHIC b73445apb7344505.gif GRAPHIC 671
  Complete submission text file 0000950135-09-001458.txt   2431186
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50743 | Film No.: 09647877
SIC: 2834 Pharmaceutical Preparations